Breaking News
Get 50% Off 0
Unlock Premium Data: Up to 50% Off InvestingPro CLAIM SALE
Close

Novartis AG (NOVN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
94.18 +0.26    +0.28%
11:19:56 - Closed. Currency in CHF ( Disclaimer )
Type:  Equity
Market:  Switzerland
ISIN:  CH0012005267 
VALOR:  1200526
  • Volume: 2,153,775
  • Bid/Ask: 94.36 / 94.34
  • Day's Range: 93.21 - 94.24
Novartis 94.18 +0.26 +0.28%

NOVN Balance Sheet

 
Featured here, the Balance Sheet for Novartis AG, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
Advanced Balance Sheet
Period Ending: 2024
31/03
2023
31/12
2023
30/09
2023
30/06
Total Current Assets 26447 30481 45660 33493
Cash and Short Term Investments 9703 14073 12816 11072
Cash - - - -
Cash & Equivalents 9469 13393 12405 10885
Short Term Investments 234 680 411 187
Total Receivables, Net 8251 9247 7099 9543
Accounts Receivables - Trade, Net 7840 7107 6819 9195
Total Inventory 5743 5913 5610 8228
Prepaid Expenses - 764 - -
Other Current Assets, Total 2750 484 20135 4650
Total Assets 94334 99945 112697 110979
Property/Plant/Equipment, Total - Net 10542 10924 10344 12277
Property/Plant/Equipment, Total - Gross - 22803 - -
Accumulated Depreciation, Total - -11879 - -
Goodwill, Net 23063 23341 23416 29522
Intangibles, Net 26272 26879 26418 28003
Long Term Investments 2102 1827 1530 1758
Note Receivable - Long Term 411 2140 280 348
Other Long Term Assets, Total 1689 1966 1701 1883
Other Assets, Total 4695 2357 22685 7565
Total Current Liabilities 29288 26390 48393 31909
Accounts Payable 4062 4926 3870 5350
Payable/Accrued - - - -
Accrued Expenses - 5174 - -
Notes Payable/Short Term Debt - 3893 - -
Current Port. of LT Debt/Capital Leases 8564 2512 5668 8536
Other Current liabilities, Total 16662 9885 38855 18023
Total Liabilities 54578 53195 74452 59048
Total Long Term Debt 18720 20034 19521 19804
Long Term Debt 17191 18436 18068 18259
Capital Lease Obligations 1529 1598 1453 1545
Deferred Income Tax 2311 2248 2457 2526
Minority Interest 81 83 81 84
Other Liabilities, Total 3512 -119 2993 3718
Total Equity 39756 46750 38245 51931
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 793 825 825 842
Additional Paid-In Capital - - - -
Retained Earnings (Accumulated Deficit) 43834 49649 42333 55682
Treasury Stock - Common -17 -41 -32 -52
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total -4854 -3683 -4881 -4541
Total Liabilities & Shareholders' Equity 94334 99945 112697 110979
Total Common Shares Outstanding 2040.41 2044.03 2055.46 2068.26
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NOVN Comments

Write your thoughts about Novartis AG
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Pablo Germain
Pablo Germain Jan 10, 2023 1:48PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Could someone explain to me today's -2%?
Mr Ride
MrRide Jan 10, 2023 1:48PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Citi analyst downgraded Novartis (SW) (NVS) from Buy to Neutral with a price target of CHF86.00 (from CHF95.00).
Chemsedine Bendaci
Chemsedine Bendaci Feb 02, 2022 2:55AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
great results coming
Chemsedine Bendaci
Chemsedine Bendaci Jan 12, 2022 6:20AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
price target 116.34 according to zone bourse
Michael Näf
Michael Näf Feb 24, 2021 6:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Now good price to go in!
Vima OG
Vima OG Feb 26, 2020 11:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Long term.
Kristof Mouton
Stoffel Sep 17, 2019 4:40PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
before investing in @novartis, read #teampia (twitter).
MoneyManager MoneyManager
Money2Manage4U Sep 17, 2019 4:40PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what refers ?
José Spescha
José Spescha Sep 17, 2019 4:40PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I can not open #teampia. What is the conclusion?
Toni Fluxá
Toni Fluxá Apr 10, 2019 8:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
botton at 81
Levo Goldberg
Levo Goldberg Apr 10, 2019 8:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hope so loaded heavily at 85....
Brunello Pianca
Brunello Pianca Jan 15, 2019 12:13PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
must hold 83.50 for uptrend to resume
Tomas Lysak DiS
Tomas Lysak DiS Aug 23, 2018 7:08AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
yes. Novartis is a good company with solid numbers.
Shadow Trader
ShadowTrader Sep 10, 2017 8:44PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Nice time to buy ? I'm not pretty sure... any one can say something about. ?. thanks to all
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email